Tau-imaging in tauopathies; Alzheimer's disease and non-AD dementias

Trial Profile

Tau-imaging in tauopathies; Alzheimer's disease and non-AD dementias

Recruiting
Phase of Trial: Phase II

Latest Information Update: 28 Sep 2017

At a glance

  • Drugs Flortaucipir F 18 (Primary)
  • Indications Alzheimer's disease; Dementia
  • Focus Diagnostic use
  • Acronyms TITAN
  • Most Recent Events

    • 16 May 2017 Planned number of patients changed from 140 to 200.
    • 30 Nov 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top